Aveeno
An American skincare and hair-care brand built around colloidal oatmeal, oat extracts, and products for dry and sensitive skin.
Last updated August 31, 2026
AI crawler reads
4requests
1companies- Anthropic4
- Profile
- 2
- Controversies
- 2
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Aveeno is an American skincare and hair-care brand whose identity is closely associated with colloidal oatmeal and oat-derived ingredients. Its products are positioned around gentle care for dry, sensitive, irritated, and condition-prone skin, with ranges spanning facial care, body moisturizers, cleansers, bath products, sun care, hair care, and baby care. The brand name is derived from Avena sativa, the scientific name for the common oat. The brand was established in 1945 by brothers Albert and Sidney Musher in collaboration with the Mayo Clinic. Their early work focused on finely milled colloidal oatmeal and its potential to soothe dry and sensitive skin. Aveeno's first product was Soothing Bath Treatment, an oatmeal-based bath preparation that established the ingredient platform later used throughout the portfolio. In 1961, the business adopted the name Aveeno Pharmaceuticals, with Albert Musher as president and Sidney Musher as vice president. Aveeno subsequently passed through several corporate owners. Cooper Laboratories acquired the brand and operated it through its Coopercare division. S.C. Johnson & Son purchased Aveeno from Cooper Laboratories in 1984, and the brand remained associated with the company's Rydelle Laboratories division until that division's name was discontinued in 1989. Johnson & Johnson acquired the company's skincare business, including Aveeno, in 1999. Under Johnson & Johnson, the packaging was redesigned and Aveeno was repositioned as a premium, naturally oriented skincare brand while retaining its mass-market distribution. During the 2000s, Aveeno broadened beyond its original bath-treatment heritage. The portfolio added soy-based products, stress-relief products, Aveeno Baby, and Skin Relief Body Wash in 2001. Positively Radiant entered facial care in 2004, followed by Clear Complexion acne care in 2005, Ultra-Calming in 2006, and Anti-Aging in 2007. These launches extended the brand into concerns including uneven tone, acne, redness, and visible signs of aging while maintaining its emphasis on ingredient-led, relatively gentle formulations. Aveeno also developed a strong association with dermatological and sensitive-skin use cases. Its products have been marketed for or used in connection with concerns such as eczema, psoriasis, urushiol-induced contact dermatitis, itching, chickenpox-related irritation, hives, and sunburn. The brand describes avenanthramides, compounds found in oats, as part of its "Active Naturals" ingredient platform. Its best-known consumer proposition combines science-informed formulation with a natural ingredient story rather than presenting the brand as a purely botanical or medicinal line. By 2014, Aveeno's US body-care products were reported to have exceeded $100 million in sales and to rank third in market share in their segment, although this historical financial information is not reproduced here without a dedicated financial source. The brand entered China through Tmall in 2016, extending its international footprint through an e-commerce-led route to market. In 2023, Aveeno moved from Johnson & Johnson to Kenvue when Johnson & Johnson separated its consumer-health business into an independent company. Reference material also reports that Kimberly-Clark acquired Kenvue in 2025. Aveeno therefore remains an active consumer skincare brand within the Kenvue portfolio, subject to the ownership structure described in the cited reference material. Its current brand promise continues to center on oat-based care, sensitive-skin expertise, broad household accessibility, and products for adults, children, and babies.
History
Aveeno originated in 1945 when brothers Albert and Sidney Musher worked with the Mayo Clinic on the use of finely milled colloidal oatmeal for dry and sensitive skin. Their first commercial product, Soothing Bath Treatment, established the core ingredient and therapeutic-care orientation that still characterize the brand. The name Aveeno comes from Avena sativa, the botanical name of the common oat. In 1961, the company changed its name to Aveeno Pharmaceuticals. Albert Musher served as president and Sidney Musher as vice president. The brand later became part of Cooper Laboratories, where it was placed within the Coopercare division. S.C. Johnson & Son acquired Aveeno from Cooper Laboratories in 1984. It was subsequently associated with S.C. Johnson's Rydelle Laboratories division, whose name was discontinued in 1989. Johnson & Johnson purchased the relevant skincare business, including Aveeno, in 1999. The new owner redesigned the packaging and repositioned the brand as a higher-end natural skincare offering. This period marked a transition from a focused oatmeal bath-treatment business to a broader consumer skincare platform. Aveeno expanded into baby care, stress-relief products, soy-based formulations, body wash, facial care, acne care, calming products, and anti-aging products during the 2000s. The brand's major 2000s extensions included Aveeno Baby and Skin Relief Body Wash in 2001; Positively Radiant facial care in 2004; Clear Complexion acne care in 2005; Ultra-Calming in 2006; and Anti-Aging in 2007. These lines allowed Aveeno to address multiple consumer concerns while preserving its association with mildness and oat-derived ingredients. Aveeno products have also been marketed for conditions and symptoms including eczema, psoriasis, contact dermatitis caused by urushiol, itching, chickenpox irritation, hives, and sunburn. Aveeno's marketing increasingly connected scientific formulation with natural ingredients. The brand identifies colloidal oats, oat extracts, and avenanthramides as central to its Active Naturals platform. It has operated across facial, body, baby, hair, bath, and sun-care categories. In 2013, Jennifer Aniston became a brand spokesperson after Daniella van Graas. In 2014, reference material reported that Aveeno's US body-care business had exceeded $100 million and held third place by market share in its segment. The brand entered China through Tmall in 2016. Aveeno became part of Kenvue in 2023 when Johnson & Johnson separated its consumer-health operations into a new company. Reference material further reports a 2025 acquisition of Kenvue by Kimberly-Clark. A further reference reports that Aveeno announced a three-year research and innovation collaboration with the Mayo Clinic in 2026, intended to advance knowledge of skin health and product development. Because the latter event is dated beyond the currently established historical record in many general references, it should be independently verified before being treated as a completed historical milestone.
- 2026
Reported Mayo Clinic research collaboration
[1]Reference material reports a three-year Aveeno and Mayo Clinic research and innovation collaboration focused on skin health and product development.
- 2025
Reported Kenvue acquisition by Kimberly-Clark
[1]Reference material reports that Kimberly-Clark acquired Kenvue, placing Aveeno within a new corporate ownership context.
- 2023
Aveeno becomes part of Kenvue
[1]Aveeno moves into Kenvue following Johnson & Johnson's separation of its consumer-health operations.
- 2016
Aveeno enters China through Tmall
[1]The brand establishes a Chinese-market presence through the Tmall e-commerce platform.
- 2007
Anti-Aging line launches
[1]Aveeno enters the anti-aging skincare segment.
- 2006
Ultra-Calming launches
[1]Aveeno adds a facial-care line aimed at calming sensitive or visibly irritated skin.
- 2005
Clear Complexion launches
[1]The brand introduces a facial acne-care range.
- 2004
Positively Radiant launches
[1]Aveeno enters facial care with the Positively Radiant line, centered on Active Soy.
- 2001
Portfolio expands into baby and skin-relief care
[1]Aveeno adds soy and stress-relief products, Aveeno Baby, and Skin Relief Body Wash.
- 1999
Johnson & Johnson acquires Aveeno's skincare business
[1]Johnson & Johnson acquires the skincare business containing Aveeno and begins a packaging and positioning refresh.
Products and positioning
A mass-to-premium accessible skincare brand emphasizing oat-based ingredients, sensitive-skin suitability, dermatological credibility, and gentle everyday care.
Bath and skin-relief treatment · 1945
Soothing Bath Treatment
Aveeno's first product, introduced from the brand's early work with the Mayo Clinic. It uses finely milled colloidal oatmeal in a bath-treatment format intended to soothe dry and irritated skin.
Body moisturization
Daily Moisturizing
A core everyday-moisturization platform associated with Aveeno's oat-based body-care positioning. Products in this family are designed for routine care of dry skin and help anchor the brand's broad household distribution.
Facial skincare · 2004
Positively Radiant
A facial-care line launched in 2004 and built around Aveeno's Active Soy ingredient platform. It broadened the brand into products addressing the appearance of uneven tone and radiance.
Acne care · 2005
Clear Complexion
An acne-care range introduced in 2005. It extended Aveeno's facial portfolio from general moisturization and radiance into blemish-oriented skincare.
Sensitive-skin facial care · 2006
Ultra-Calming
A facial-care platform launched in 2006 for consumers seeking products associated with calming visibly sensitive or irritated skin. It reinforces Aveeno's sensitive-skin specialization.
Baby skincare · 2001
Aveeno Baby
A baby-care portfolio introduced during Aveeno's early-2000s expansion. It applies the brand's gentle, oat-centered positioning to cleansing, moisturizing, and routine care for babies.
Body care and skin relief · 2001
Skin Relief
A body-care platform associated with dry, itchy, and sensitive-skin needs. The range includes body washes and moisturizers and reflects Aveeno's connection with dermatological skin-relief use cases.
Controversies
2023
Legal action following sunscreen recall
Legal action connected with the aerosol sunscreen contamination and recall was reported as settled in 2023.
2021
Aerosol sunscreen benzene recall
Several Aveeno and Neutrogena aerosol sunscreens were recalled in the United States after benzene was detected. Johnson & Johnson stated that benzene was not used as an intended manufacturing ingredient and said it was investigating the contamination source.
2021
Consumers file class-action lawsuit over recalled sunscreens
Johanna Dominguez and Sharron Meijer filed a class-action lawsuit against Johnson & Johnson in the U.S. District Court for the Northern District of California over affected sunscreen products, seeking an injunction and damages on behalf of consumers.
2021
Johnson & Johnson recalls aerosol sunscreens
Johnson & Johnson announced a voluntary recall of several Neutrogena and Aveeno sunscreen products after samples were found to contain benzene, a known carcinogen. The company said detected levels should be harmless and that it was investigating how the chemical got into the products.
Criticism over microbeads
Aveeno was criticized for selling products containing microbeads, plastic particles that may pass through wastewater systems and reach aquatic environments. Johnson & Johnson stated that it would remove microbeads from its products by 2017.
Marketing campaigns
- 2013Jennifer Aniston spokesperson campaign
United States · International markets
Aveeno appointed Jennifer Aniston as a spokesperson, using a high-profile celebrity partnership to support the brand's accessible premium skincare and natural-ingredient positioning.
Outcome. Aniston replaced long-serving spokesperson Daniella van Graas; longer-term campaign performance is not specified in the available reference.
Brand decisions
2026
Reported Mayo Clinic research collaborationStrategyBackground
Reference material describes a planned effort to deepen research into skin health and product innovation.
Action taken
Aveeno reportedly announced a three-year research and innovation collaboration with the Mayo Clinic.
Aftermath
The collaboration's results are not specified. The reported event requires independent verification.
2023
Transfer to KenvueM&ABackground
Johnson & Johnson separated its consumer-health operations into Kenvue.
Action taken
Aveeno became part of Kenvue's consumer-health and personal-care portfolio.
Aftermath
Aveeno continued as an active standalone brand under the new corporate structure.
2004
Entry into facial skincareProduct launchBackground
Aveeno sought to extend its oatmeal-centered body and bath-care heritage into facial skincare.
Action taken
The brand launched Positively Radiant, based on its Active Soy ingredient platform.
Aftermath
The launch established facial care as a significant part of the brand's category architecture.
1999
Johnson & Johnson acquires the brandM&ABackground
Aveeno's skincare business was acquired as part of Johnson & Johnson's expansion of its consumer-health and skincare portfolio.
Action taken
Johnson & Johnson acquired the business and subsequently redesigned Aveeno packaging and repositioned the brand as a higher-end natural skincare offering.
Aftermath
The move preceded a broad expansion into facial, baby, acne, calming, and anti-aging categories.
Recent events
Reported
Aveeno launches #SkinVisibility campaign[5]
Aveeno announced and launched its #SkinVisibility campaign to address the underdiagnosis, care and treatment of eczema on Black skin. The campaign includes educational resources, tools and products, and the brand said it aims to help 100,000 people with eczema find relief in the next six months.
- Unconfirmed
Consumers file class-action lawsuit over recalled sunscreens[3]
Johanna Dominguez and Sharron Meijer filed a class-action lawsuit against Johnson & Johnson in the U.S. District Court for the Northern District of California over affected sunscreen products, seeking an injunction and damages on behalf of consumers.
- Unconfirmed
Johnson & Johnson recalls aerosol sunscreens[4]
Johnson & Johnson announced a voluntary recall of several Neutrogena and Aveeno sunscreen products after samples were found to contain benzene, a known carcinogen. The company said detected levels should be harmless and that it was investigating how the chemical got into the products.
Sources6 sources
Cite this profile: Cite the canonical profile. /brand-wiki/aveeno · Editorial policy · How profiles are compiled